Issue 2/2016

Role of pericytes in angiogenesis: focus on cancer angiogenesis and anti-angiogenic therapy (173 — 182)

Z. CHEN, X. H. XU, J. HU

DOI: 10.4149/201_150704N369

Endosialin: molecular and functional links to tumor angiogenesis (183 — 192)

S. KONTSEKOVA, K. POLCICOVA, M. TAKACOVA, S. PASTOREKOVA

DOI: 10.4149/202_15090N474

Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice (193 — 200)

L. LIU, S. QIU, Y. LIU, Z. LIU, Y. ZHENG, X. SU, B. CHEN, H. CHEN

DOI: 10.4149/203_150422N214

Adenosine inhibits migration, invasion and induces apoptosis of human cervical cancer cells (201 — 207)

Z. W. GAO, H. P. WANG, K. DONG, F. LIN, X. WANG, H. Z. ZHANG

DOI: 10.4149/204_150723N407

Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway (208 — 214)

J. LI, K. L. HUANG, T. ZHANG, H. LI, J. ZHAO, H. WANG

DOI: 10.4149/205_150601N306

Anti-tumor role of Bacillus subtilis fmbJ-derived fengycin on human colon cancer HT29 cell line (215 — 222)

W. CHENG, Y. Q. FENG, J. REN, D. JING, C. WANG

DOI: 10.4149/206_150518N270

H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer (223 — 230)

J. S. CHEN, Y. F. WANG, X. Q. ZHANG, J. M. LV, Y. LI, X. X. LIU, T. P. XU

DOI: 10.4149/207_150821N454

Claudin-1, -3, -4 and -7 gene expression analyses in canine prostate carcinoma and mammary tissue derived cell lines (231 — 238)

S. C. HAMMER, S. NAGEL, J. JUNGINGER, M. HEWICKER-TRAUTWEIN, S. WAGNER, A. HEISTERKAMP, A. NGEZAHAYO, I. NOLTE, H. MURUA ESCOBAR

DOI: 10.4149/208_150924N505

Discovery of signature genes in gastric cancer associated with prognosis (239 — 245)

X. ZHAO, H. CAI, X. WANG, L. MA

DOI: 10.4149/209_150531N303

The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders (246 — 253)

M. KONECNY, J. MARKUS, I. WACZULIKOVA, L. DOLESOVA, R. KOZLOVA, V. REPISKA, H. NOVOSADOVA, I. MAJER

DOI: 10.4149/210_150419N208

Expression of lipid metabolism-related proteins in breast phyllodes tumors (254 — 262)

Y. Y. JUNG, Y. K. LEE, J. S. KOO

DOI: 10.4149/211_150715N393

Genetic risk factors of cisplatin induced ototoxicity in adult patients (263 — 268)

T. TALACH, J. ROTTENBERG, B. GAL, R. KOSTRICA, M. JURAJDA, I. KOCAK, R. LAKOMY, E. VOGAZIANOS

DOI: 10.4149/212_140820N391

Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience (269 — 273)

L. LAMBERT, J. HOREJS, Z. KRSKA, D. HOSKOVEC, L. PETRUZELKA, T. KRECHLER, P KRIZ, J. BRIZA

DOI: 10.4149/213_150611N326

Overexpression of filamin-A protein is associated with aggressive phenotype and poor survival outcomes in NSCLC patients treated with platinum-based combination chemotherapy (274 — 281)

M. GACHECHILADZE, J. SKARDA, M. JANIKOVA, G. MGEBRISHVILI, G. KHARAISHVILI, V. KOLEK, I. GRYGARKOVA, J. KLEIN, A. POPRACHOVA, M. ARABULI, Z. KOLAR

DOI: 10.4149/214_150224N108

Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma (282 — 287)

A. SHIMIZU, K. KAIRA, M. YASUDA, T. ASAO, O. ISHIKAWA

DOI: 10.4149/215_150714N389

The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection (288 — 298)

R. C. ZHAO, J. ZHOU, K. F. CHEN, J. GONG, J. LIU, J. Y. HE, P. GUAN, B. LI, Y. QIN

DOI: 10.4149/neo_2016_036

Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites (299 — 303)

C. LU, L. LI, Z. LUO, Y. CUI, P. FU, J. ZHOU, N. MA, Y. ZHOU

DOI: 10.4149/217_150622N345

CyberKnife stereotactic radiosurgery and stereotactic ablative radiation therapy of patients with prostate cancer bone metastases. (304 — 312)

A. NAPIERALSKA, L. MISZCZYK, M. STAPOR-FUDZINSKA

DOI: 10.4149/218_150807N435

Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor (313 — 321)

D. SOBIC SARANOVIC, M. STOJILJKOVIC, S. SUSNJAR, S. ODALOVIC, V. ARTIKO, S. PAVLOVIC, I. GROZDIC-MILOJEVIC, V. OBRADOVIC

DOI: 10.4149/219_150813N440

A two kinase-gene signature model using CDK2 and PAK4 expression predicts poor outcome in non-small cell lung cancers (322 — 329)

X. WANG, Y. LU, W. FENG, Q. CHEN, H. GUO, X. SUN, Y. BAO

DOI: 10.4149/220_150817N448